Xiphodynia masking acute myocardial infarction: a diagnostic cul-de-sac.
A 52-year-old hypertensive woman is described in whom a clinically evident diagnosis of xiphodynia, the painful xiphoid process, complicated the diagnosis of impending myocardial infarction. The authors suggest that xiphodynia be considered a second-line assumption after more dangerous conditions have been thoroughly ruled out.
Koren
W
W
Department of Emergency Medicine, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Hashomer, Israel.
Shahar
A
A
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002637:Chest Pain / Q000175:diagnosis* / Q000188:drug therapy; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D004008:Diclofenac / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007964:Leukocytosis / Q000150:complications; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009504:Neutrophils; D014989:Xiphoid Bone / Q000473:pathology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D004008:Diclofenac; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase